PAPER
SEARCH RESULTS
329963 RESULTS
PAPER Bouter Y, Noguerola JS, Tucholla P, Crespi GA, Parker MW, Wiltfang J, Miles LA, Bayer TA
Correction: Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncted Abeta in sporadic Alzheimer disease cases and mouse models.
Acta Neuropathol. 2024 Mar 25;147(1):59. PubMed: 38526686PAPER Vajedi FS, Rasoolzadeh R, Angnes L, Santos EC, Silva LP
Ultrasensitive Aptasensing Platform for the Detection of β-Amyloid-42 Peptide Based on MOF Containing Bimetallic Porphyrin Graphene Oxide and Gold Nanoparticles.
ACS Appl Bio Mater. 2024 Mar 25; PubMed: 38527228PAPER Chen G, Johansson J
Potential of molecular chaperones for treating Alzheimer's disease.
Neural Regen Res. 2024 Nov 1;19(11):2343-2344. Epub 2024 Mar 8 PubMed: 38526266PAPER Hu B, Zhang J, Huang J, Luo B, Zeng X, Jia J
NLRP3/1-mediated pyroptosis: beneficial clues for the development of novel therapies for Alzheimer's disease.
Neural Regen Res. 2024 Nov 1;19(11):2400-2410. Epub 2023 Dec 21 PubMed: 38526276PAPER Lindner K, Gavin AC
Isoform- and cell-state-specific APOE homeostasis and function.
Neural Regen Res. 2024 Nov 1;19(11):2456-2466. Epub 2024 Jan 31 PubMed: 38526282PAPER Mahdy S, Abuelmakarem HS
Alzheimer's disease progression detection based on optical fluence rate measurements using alternative laser wavelengths.
Int J Numer Method Biomed Eng. 2024 Mar 25;:e3816. PubMed: 38523567PAPER Yuan M, Lian S, Li X, Long X, Fang Y, Alzheimer's Disease Neuroimaging Initiative (ADNI)
Blood biomarkers in dynamic prediction of conversion to Alzheimer's disease: An application of joint modeling.
Int J Geriatr Psychiatry. 2024 Mar;39(3):e6079. PubMed: 38526446PAPER Kaur B, Kaur R, Vivesh, Rani S, Bhatti R, Singh P
Small Peptides Targeting BACE-1, AChE, and A-β Reversing Scopolamine-Induced Memory Impairment: A Multitarget Approach against Alzheimer's Disease.
ACS Omega. 2024 Mar 19;9(11):12896-12913. Epub 2024 Mar 4 PubMed: 38524457PAPER Buckley RF, Schindler SE
Lower Accuracy Alzheimer Disease Blood Tests Will Never Be "Ready for Prime Time".
Neurology. 2024 Apr 23;102(8):e209295. Epub 2024 Mar 25 PubMed: 38527244PAPER Yang T, Guo Z, Li J, Zhu H, Cao Y, Ding Y, Liu X
Abnormally decreased functional connectivity of the right nucleus basalis of Meynert in Alzheimer's disease patients with depression symptoms.
Biol Psychol. 2024 Mar 26;188:108785. PubMed: 38527571PAPER Blurton-Jones M, Spencer B, Michael S, Castello NA, Agazaryan AA, Davis JL, Müller FJ, Loring JF, Masliah E, LaFerla FM
Correction: Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models.
Stem Cell Res Ther. 2024 Mar 25;15(1):88. PubMed: 38523285PAPER Robinson CG, Goodrich AW, Weigand SD, Pham NT, Carlos AF, Buciuc M, Murray ME, Nguyen AT, Reichard RR, Knopman DS, Petersen RC, Dickson DW, Utianski RL, Whitwell JL, Josephs KA, Machulda MM
Determinants of confrontation naming deficits on the Boston Naming Test associated with transactive response DNA-binding protein 43 pathology.
J Int Neuropsychol Soc. 2024 Mar 25;:1-9. PubMed: 38525671PAPER Cheong I, Du Y, Smith G, Hua J, Li X, Pantelyat A
Cerebral tau deposition in co-morbid progressive supranuclear palsy and amyotrophic lateral sclerosis: an [18F]-flortaucipir and 7T MRI study.
Neurodegener Dis. 2024 Mar 25; PubMed: 38527450PAPER Amian JG, Fernandez-Portero C, de la Bella R, Arenilla-Villalba MJ, López-Lluch G, Alarcon D
Cognitive Reserve and Frontotemporal Disorders: Exploring the Relationship Between Education, Physical Activity, and Cognitive Dysfunction in Older Adults.
Percept Mot Skills. 2024 Mar 25;:315125241241358. PubMed: 38523555Current Filters
No filters selected